Cargando…

COVID-19 Is a Multifaceted Challenging Pandemic Which Needs Urgent Public Health Interventions

Until less than two decades ago, all known human coronaviruses (CoV) caused diseases so mild that they did not stimulate further advanced CoV research. In 2002 and following years, the scenario changed dramatically with the advent of the new more pathogenic CoVs, including Severe Acute Respiratory S...

Descripción completa

Detalles Bibliográficos
Autores principales: Contini, Carlo, Caselli, Elisabetta, Martini, Fernanda, Maritati, Martina, Torreggiani, Elena, Seraceni, Silva, Vesce, Fortunato, Perri, Paolo, Rizzo, Leonzio, Tognon, Mauro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464234/
https://www.ncbi.nlm.nih.gov/pubmed/32806657
http://dx.doi.org/10.3390/microorganisms8081228
_version_ 1783577317168119808
author Contini, Carlo
Caselli, Elisabetta
Martini, Fernanda
Maritati, Martina
Torreggiani, Elena
Seraceni, Silva
Vesce, Fortunato
Perri, Paolo
Rizzo, Leonzio
Tognon, Mauro
author_facet Contini, Carlo
Caselli, Elisabetta
Martini, Fernanda
Maritati, Martina
Torreggiani, Elena
Seraceni, Silva
Vesce, Fortunato
Perri, Paolo
Rizzo, Leonzio
Tognon, Mauro
author_sort Contini, Carlo
collection PubMed
description Until less than two decades ago, all known human coronaviruses (CoV) caused diseases so mild that they did not stimulate further advanced CoV research. In 2002 and following years, the scenario changed dramatically with the advent of the new more pathogenic CoVs, including Severe Acute Respiratory Syndome (SARS-CoV-1), Middle Eastern respiratory syndrome (MERS)-CoV, and the new zoonotic SARS-CoV-2, likely originated from bat species and responsible for the present coronavirus disease (COVID-19), which to date has caused 15,581,007 confirmed cases and 635,173 deaths in 208 countries, including Italy. SARS-CoV-2 transmission is mainly airborne via droplets generated by symptomatic patients, and possibly asymptomatic individuals during incubation of the disease, although for the latter, there are no certain data yet. However, research on asymptomatic viral infection is currently ongoing worldwide to elucidate the real prevalence and mortality of the disease. From a clinical point of view, COVID-19 would be defined as “COVID Planet “ because it presents as a multifaceted disease, due to the large number of organs and tissues infected by the virus. Overall, based on the available published data, 80.9% of patients infected by SARS-CoV-2 develop a mild disease/infection, 13.8% severe pneumonia, 4.7% respiratory failure, septic shock, or multi-organ failure, and 3% of these cases are fatal, but mortality parameter is highly variable in different countries. Clinically, SARS-CoV-2 causes severe primary interstitial viral pneumonia and a “cytokine storm syndrome”, characterized by a severe and fatal uncontrolled systemic inflammatory response triggered by the activation of interleukin 6 (IL-6) with development of endothelitis and generalized thrombosis that can lead to organ failure and death. Risk factors include advanced age and comorbidities including hypertension, diabetes, and cardiovascular disease. Virus entry occurs via binding the angiotensin-converting enzyme 2 (ACE2) receptor present in almost all tissues and organs through the Spike (S) protein. Currently, SARS-CoV-2 infection is prevented by the use of masks, social distancing, and improved hand hygiene measures. This review summarizes the current knowledge on the main biological and clinical features of the SARS-CoV-2 pandemic, also focusing on the principal measures taken in some Italian regions to face the emergency and on the most important treatments used to manage the COVID-19 pandemic.
format Online
Article
Text
id pubmed-7464234
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74642342020-09-04 COVID-19 Is a Multifaceted Challenging Pandemic Which Needs Urgent Public Health Interventions Contini, Carlo Caselli, Elisabetta Martini, Fernanda Maritati, Martina Torreggiani, Elena Seraceni, Silva Vesce, Fortunato Perri, Paolo Rizzo, Leonzio Tognon, Mauro Microorganisms Review Until less than two decades ago, all known human coronaviruses (CoV) caused diseases so mild that they did not stimulate further advanced CoV research. In 2002 and following years, the scenario changed dramatically with the advent of the new more pathogenic CoVs, including Severe Acute Respiratory Syndome (SARS-CoV-1), Middle Eastern respiratory syndrome (MERS)-CoV, and the new zoonotic SARS-CoV-2, likely originated from bat species and responsible for the present coronavirus disease (COVID-19), which to date has caused 15,581,007 confirmed cases and 635,173 deaths in 208 countries, including Italy. SARS-CoV-2 transmission is mainly airborne via droplets generated by symptomatic patients, and possibly asymptomatic individuals during incubation of the disease, although for the latter, there are no certain data yet. However, research on asymptomatic viral infection is currently ongoing worldwide to elucidate the real prevalence and mortality of the disease. From a clinical point of view, COVID-19 would be defined as “COVID Planet “ because it presents as a multifaceted disease, due to the large number of organs and tissues infected by the virus. Overall, based on the available published data, 80.9% of patients infected by SARS-CoV-2 develop a mild disease/infection, 13.8% severe pneumonia, 4.7% respiratory failure, septic shock, or multi-organ failure, and 3% of these cases are fatal, but mortality parameter is highly variable in different countries. Clinically, SARS-CoV-2 causes severe primary interstitial viral pneumonia and a “cytokine storm syndrome”, characterized by a severe and fatal uncontrolled systemic inflammatory response triggered by the activation of interleukin 6 (IL-6) with development of endothelitis and generalized thrombosis that can lead to organ failure and death. Risk factors include advanced age and comorbidities including hypertension, diabetes, and cardiovascular disease. Virus entry occurs via binding the angiotensin-converting enzyme 2 (ACE2) receptor present in almost all tissues and organs through the Spike (S) protein. Currently, SARS-CoV-2 infection is prevented by the use of masks, social distancing, and improved hand hygiene measures. This review summarizes the current knowledge on the main biological and clinical features of the SARS-CoV-2 pandemic, also focusing on the principal measures taken in some Italian regions to face the emergency and on the most important treatments used to manage the COVID-19 pandemic. MDPI 2020-08-12 /pmc/articles/PMC7464234/ /pubmed/32806657 http://dx.doi.org/10.3390/microorganisms8081228 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Contini, Carlo
Caselli, Elisabetta
Martini, Fernanda
Maritati, Martina
Torreggiani, Elena
Seraceni, Silva
Vesce, Fortunato
Perri, Paolo
Rizzo, Leonzio
Tognon, Mauro
COVID-19 Is a Multifaceted Challenging Pandemic Which Needs Urgent Public Health Interventions
title COVID-19 Is a Multifaceted Challenging Pandemic Which Needs Urgent Public Health Interventions
title_full COVID-19 Is a Multifaceted Challenging Pandemic Which Needs Urgent Public Health Interventions
title_fullStr COVID-19 Is a Multifaceted Challenging Pandemic Which Needs Urgent Public Health Interventions
title_full_unstemmed COVID-19 Is a Multifaceted Challenging Pandemic Which Needs Urgent Public Health Interventions
title_short COVID-19 Is a Multifaceted Challenging Pandemic Which Needs Urgent Public Health Interventions
title_sort covid-19 is a multifaceted challenging pandemic which needs urgent public health interventions
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464234/
https://www.ncbi.nlm.nih.gov/pubmed/32806657
http://dx.doi.org/10.3390/microorganisms8081228
work_keys_str_mv AT continicarlo covid19isamultifacetedchallengingpandemicwhichneedsurgentpublichealthinterventions
AT casellielisabetta covid19isamultifacetedchallengingpandemicwhichneedsurgentpublichealthinterventions
AT martinifernanda covid19isamultifacetedchallengingpandemicwhichneedsurgentpublichealthinterventions
AT maritatimartina covid19isamultifacetedchallengingpandemicwhichneedsurgentpublichealthinterventions
AT torreggianielena covid19isamultifacetedchallengingpandemicwhichneedsurgentpublichealthinterventions
AT seracenisilva covid19isamultifacetedchallengingpandemicwhichneedsurgentpublichealthinterventions
AT vescefortunato covid19isamultifacetedchallengingpandemicwhichneedsurgentpublichealthinterventions
AT perripaolo covid19isamultifacetedchallengingpandemicwhichneedsurgentpublichealthinterventions
AT rizzoleonzio covid19isamultifacetedchallengingpandemicwhichneedsurgentpublichealthinterventions
AT tognonmauro covid19isamultifacetedchallengingpandemicwhichneedsurgentpublichealthinterventions